| __timestamp | Amphastar Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 12402000000 |
| Thursday, January 1, 2015 | 37065000 | 17449000000 |
| Friday, January 1, 2016 | 41199000 | 17834000000 |
| Sunday, January 1, 2017 | 43415000 | 19551000000 |
| Monday, January 1, 2018 | 57564000 | 18265000000 |
| Tuesday, January 1, 2019 | 68853000 | 15607000000 |
| Wednesday, January 1, 2020 | 67229000 | 15410000000 |
| Friday, January 1, 2021 | 60932000 | 16541000000 |
| Saturday, January 1, 2022 | 74771000 | 17482000000 |
| Sunday, January 1, 2023 | 73741000 | 19381000000 |
| Monday, January 1, 2024 | 22873000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, innovation is the key to staying ahead. Dr. Reddy's Laboratories Limited and Amphastar Pharmaceuticals, Inc. are two prominent players, each with a distinct approach to research and development (R&D) investment. Over the past decade, Dr. Reddy's has consistently outpaced Amphastar, investing nearly 30 times more in R&D annually. For instance, in 2023, Dr. Reddy's allocated approximately $19.4 billion, while Amphastar invested around $74 million. This trend highlights Dr. Reddy's commitment to innovation, with a steady increase in R&D spending, peaking in 2024. Meanwhile, Amphastar's investment, though growing, remains modest in comparison. The data underscores the strategic priorities of these companies, with Dr. Reddy's focusing heavily on innovation to drive growth and maintain its competitive edge. Missing data for Amphastar in 2024 suggests a potential shift or reevaluation in their R&D strategy.
Comparing Innovation Spending: Amgen Inc. and Dr. Reddy's Laboratories Limited
Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Gilead Sciences, Inc. vs Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs Verona Pharma plc
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs CymaBay Therapeutics, Inc.
R&D Spending Showdown: Dr. Reddy's Laboratories Limited vs ImmunityBio, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and MorphoSys AG
Dr. Reddy's Laboratories Limited vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Novavax, Inc.
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending